Search results
FDA advisory panel recommends new Alzheimer's drug after scrutiny - UPI.com
UPI· 30 minutes agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 18 hours agoMock says Moderna will go to the FDA to determine the path to approval. If approved, this would be...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 1 day agoModerna expects to present the Phase...Moderna has not said when the combination vaccine might be evaluated by the FDA. Both Pfizer-BioNTech ...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 24 hours agoThe combo shot could become the company’s third product on the market, after the U.S. Food and Drug...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 1 day agoModerna also tested immune responses against the B/Yamagata strain of influenza....
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoModerna will rival Pfizer and GSK, which launched their...in June, Moderna and Merck announced three...
Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season
FierceBiotech· 1 day agoModerna’s combo flu and COVID-19 vaccine zipped through a late-stage trial this winter, and the...
Moderna says its combination Covid and flu vaccine works well in late-stage trial
NBC NEWS· 23 hours agoModerna said on Monday its combination vaccine to protect against both Covid and influenza generated...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN via Yahoo News· 1 day agoStudy...statistically significant higher immune response against three strains of the flu and against Covid...of safety, the combined vaccine was well-tolerated, ...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 4 days agoGlobal vaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and...